NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Scott McDonnell
Ferring International Center S.A - / Switzerland
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4984982
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Scott McDonnell's MOST POPULAR ARTICLES
1-)
An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms HY Zou, Q Li, JH Lee, ME Arango, SR McDonnell, S Yamazaki, ... Cancer research 67 (9), 4408-4417, 2007 8582007
2-)
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma JG Christensen, HY Zou, ME Arango, Q Li, JH Lee, SR McDonnell, ... Molecular cancer therapeutics 6 (12), 3314-3322, 2007 7492007
3-)
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations HY Zou, Q Li, LD Engstrom, M West, V Appleman, KA Wong, M McTigue, ... Proceedings of the National Academy of Sciences 112 (11), 3493-3498, 2015 2352015
4-)
The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesisLM McAllister-Lucas, X Jin, S Gu, K Siu, S McDonnell, J Ruland, ...Journal of Biological Chemistry 285 (34), 25880-25884, 2010882010
5-)
Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK–mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphomaSRP McDonnell, SR Hwang, D Rolland, C Murga-Zamalloa, V Basrur, ...Blood, The Journal of the American Society of Hematology 122 (6), 958-968, 2013712013
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept